HLA
IMDZ

Hamilton Lane Advisors’s Immune Design Corp. IMDZ Stock Holding History

Hamilton Lane Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,312
Closed -$365K – 81
2015
Q1 		$365K Sell
17,312
-25,500
-60% -$665K 0.17% 41
2014
Q4 		$1.32M Buy
+42,812
New +$1.19M 0.5% 31

Other funds holding IMDZ

CGL
Column Group LP San Francisco, California $38.6M AUM 30.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hamilton Lane Advisors's IMDZ Position: Q2 2015 in Review

Hamilton Lane Advisors sold out of Immune Design Corp. (IMDZ) in Q2 2015, closing a stake of 17,312 shares — an estimated $365K sold.

Hamilton Lane Advisors first reported a position in IMDZ in Q4 2014 and held it in 2 quarters. The position peaked at $1.32M in Q4 2014. 62 funds tracked by Wall St. Rank hold IMDZ as of Q2 2015.

  • Hamilton Lane Advisors reported no remaining Immune Design Corp. position as of Q2 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 17,312 Immune Design Corp. shares in Q2 2015, an estimated $365K.
  • Hamilton Lane Advisors first reported a position in Immune Design Corp. in Q4 2014 and held it in 2 quarters.
  • Hamilton Lane Advisors's Immune Design Corp. position peaked at $1.32M in Q4 2014.
  • 62 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2015.

Based on Hamilton Lane Advisors's 13F filing for Q2 2015, filed 23 Jul 2015.